Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.24M | $3.68M | $42.5K | $12.5M | $37.3M | $92.9M | $119M | $153M | $155M | $194M |
| Revenue growth | — | -29.7% | -98.8% | 29227.5% | 199.1% | 149.0% | 28.2% | 28.2% | 1.5% | 25.3% |
| Gross profit | $3.29M | $2.66M | $6.33M | $9.94M | $28.4M | $74.9M | $100M | $134M | $133M | $166M |
| Gross margin | 62.9% | 72.4% | 14883.9% | 79.7% | 76.2% | 80.6% | 84.3% | 87.6% | 86.2% | 85.7% |
| Operating income | -$1.17M | -$1.23M | -$2.06M | -$2.89M | -$57.8M | -$54.3M | -$43.4M | -$14.5M | -$20.4M | -$7.67M |
| Operating margin | -22.4% | -33.4% | -4836.3% | -23.2% | -155.0% | -58.5% | -36.5% | -9.5% | -13.2% | -4.0% |
| Net income | -$1.11M | -$1.21M | -$1.24M | -$3.14M | -$58.6M | -$60.9M | -$45.5M | -$20.6M | -$21.4M | $14.4M |
| Net margin | -21.1% | -32.8% | -2918.6% | -25.2% | -157.3% | -65.6% | -38.3% | -13.5% | -13.8% | 7.4% |
| EPS (diluted) | -$0.03 | -$0.03 | — | — | — | — | — | — | -$0.60 | $0.25 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$408K | -$817K | -$906K | $251K | -$12.1M | -$33.1M | -$22.9M | $8.82M | $17.5M | $8.28M |
| Capital expenditures | — | — | — | — | — | $247K | $367K | $204K | $1.46M | $1.87M |
| Free cash flow | — | — | — | — | — | -$33.3M | -$23.3M | $8.62M | $16.0M | $6.41M |
| Share buybacks | — | $76.6K | — | — | — | — | — | — | — | $270K |
| Dividends paid | — | — | — | — | — | $871K | $3.11M | $3.11M | $3.11M | $3.11M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $183K | $141K | $180K | $1.11M | $9.18M | $41.3M | $3.96M | $33.1M | $32.7M | $36.8M |
| Total assets | $790K | $1.26M | $2.62M | $3.45M | $13.4M | $49.9M | $25.7M | $58.5M | $76.1M | $70.4M |
| Total liabilities | — | $641K | $1.80M | $4.58M | $14.2M | $24.1M | $33.0M | $52.9M | $83.7M | $47.3M |
| Shareholders' equity | -$355K | $882K | $898K | -$988K | -$2.30M | $22.7M | -$11.4M | $3.51M | -$9.08M | $23.2M |
| Retained earnings | -$9.69M | -$10.9M | -$12.1M | -$16.6M | -$80.2M | -$142M | -$191M | -$214M | -$240M | -$229M |
| Shares (wtd avg diluted) | 33.5M | 41.7M | 44.2M | 9.90M | 14.3M | 27.0M | 31.0M | 33.9M | 41.2M | 45.1M |
Every figure is extracted from LifeMD, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.